Selection and management of candidates for heart transplantation

Current Opinion in Cardiology

Volumn 11, Issue 2, 1996, Pages 166-173

  Stevenson, Lynne Warner ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEART FAILURE; HEART TRANSPLANTATION; HUMAN; ORGAN DONOR; OXYGEN CONSUMPTION; PATIENT SELECTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; SOCIAL PSYCHOLOGY;

HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HEMODYNAMIC PROCESSES; HUMANS; PALLIATIVE CARE; PATIENT CARE TEAM; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; SURVIVAL RATE; TISSUE DONORS; TREATMENT OUTCOME;

EID: 0029925384     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-199603000-00010     Document Type: Review

References (54)

1. Steimle AE, Stevenson LW, Fonarow GC, Hamilton MA, Moriguch JD: Prediction of improvement in recent onset cardiomyopathy after referral for heart transplantation. J Am Coll Cardiol 1994, 23:553-559.
2. Semigran MJ, Thaik CM, Fifer MA, Boucher CA, Palacios IG, Dec GW: Exercise capacity and systolic and diastolic ventricular function after recovery from acute dilated cardiomyopathy. J Am Coll Cardiol 1994, 24:462-470.
3. Elefteriades JA, Kron IL: Coronary artery bypass grafting in advanced left ventricular dysfunction. Cardiol Clin 1995, 13:35-42. A thoughtful review of recent data on revascularization in patients with low left ventricular ejection fraction, emphasizing both the potential for improvement and the risks, which are high in patients with poor distal vessels.
4. Bach DS, Bolling SF: Early improvement in congestive heart failure after correction of secondary mitral regurgitation in end-stage cardiomyopathy. Am Heart J 1995, 129:1165-1170. A preliminary report of 9 patients undergoing surgery for secondary mitral regurgitation, demonstrating improvement in left ventricular function and no operative deaths.
5. Middlekauff HR, Weiner I, Stevenson WG: Low-dose amiodarone for atrial fibrillation. Am J Cardiol 1993, 72:75F-80F.
6. Alexander JK: The cardiomyopathy of obesity. Prog Cardiovasc Dis 1985, 27:325-334.
7. Agostoni PG, Marenzi GC, Pepi M, Doria E, Salvioni A, Perego G, Lauri G, Giraldi F, Grazi S, Guazzi MD: Isolated ultrafiltration in moderate congestive heart failure. J Am Coll Cardiol 1993; 424-431.
8. Erlebacher JA, Bhardwaj M, Suresh A, Leber GB, Goldweit RS: Beta-blocker treatment of idiopathic and ischemic dilated cardiomyopathy in patients with ejection fractions ≤ 20%. Am J Cardiol 1993, 71:1467-1469.
9. Krum H, Sackner-Bernstein JD, Goldsmith RL, Kukin ML, Schwartz B, Penn J, Medina N, Yushak M, Horn E, Katz SD, Levin HR, Neuberg GW, DeLong G, Packer M: Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure. Circulation 1995, 92:1499-1506. A well-designed study of carvedilol, the β-adrenergic blocking agent with vasodilation and other properties, in 56 patients with moderate-severe heart failure. After frequent worsening of congestive symptoms during initiation of therapy, there was significant improvement in left ventricular function and clinical status over the 14 weeks.
10. Doval HC, Nul DR, Grancelli HO, Perrone SV, Bortman GR, Curiel R for Grupo de Estudio de la Sobrevida en la Insuficienceia Cardiac en Argentina (GESICA): Randomized trial of low-dose amiodarone in severe congestive heart failure. Lancet 1994, 344:493-498.
11. Singh SN, Fletcher RD, Fisher SG, Singh BN, Lewis HD, Deedwania PC, Massie BM, Colling C, Lazzeri D: Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med 1995, 333:77-82. A multicenter randomized controlled trial of amiodarone in 674 patients with mild-moderate heart failure and baseline ventricular ectopy. The treatment group had significant improvement in left ventricular ejection fraction without change in mortality, although there was a favorable trend in the nonischemic patients.
12. Mahmarian JJ, Smart FW, Moye LA, Young JB, Francis MJ, Kingry CL, et al.: Exploring the minimal dose of amiodarone with antiarrhythmic and hemodynamic activity. Am J Cardiol 1994, 74:681-686.
13. Flaker GC, Blackshear JL, McBridge R, et al.: Predictors of thromboembolism in atrial fibrillation. Clinical features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators. Ann Int Med 1992, 116:2-8.
14. Natterson PD, Stevenson WG, Saxon LA, Middlekauff HR, Stevenson LW: Risk of arterial embolization in 224 patients awaiting cardiac transplantation. Am Heart J 1995, 129:564-570. A descriptive study of 224 transplant candidates followed for a year, during which 3% of patients had clinical embolic events.
15. Konstam MA, et al.: Heart failure: evaluation and care of patients with left ventricular dysfunction. In Clinical practice guidelines. U.S. Dept of Health and Human Services, 1994. An excellent, detailed presentation of current information and practice guidelines and dilemmas reflecting careful consensus from a multidisciplinary team experienced in the clinical management of heart failure. The executive summary at the beginning provides the information in concise form.
16. ACC/AHA Task Force Report: Guidelines for the evaluation and management of heart failure. J Am Coll Cardiol 1995, 26:1376-1398. A summary of diagnostic and therapeutic interventions for both acute and chronic heart failure considered indicated, possibly indicated, or not indicated by a broad panel of experts.
17. Lofaso F, Verschueren P, Rande JLD, Harf A, Goldeberg F: Prevalence of sleep-disordered breathing in patients on a heart transplant waiting list. Chest 1994, 106:1689-1694.
18. Naughton MT, Rahman A, Hara K, Floras JS, Bradley TD: Effect of CPAP on intrathoracic and left ventricular transmural pressures in patients with congestive heart failure. Circulation 1995, 91:1725.
19. Sweeney MO, Ruskin RN, Garan H, McGovern BA, Guy ML, Torchiana DF, Vlahakes GJ, Newall JB, Semigran MJ, Dec GW: Influence of the implantable cardioverter/defibrillator on sudden death and total mortality in patients evaluated for cardiac transplantation. Circulation 1995, 92:3273-3281. Recent experience with implantable cardioverter-defibrillators in heart transplant candidates, demonstrating an impact on sudden death without a significant effect on overall mortality. Four of five sudden deaths in device recipients were preceded by successful defibrillation followed by bradycardia or electromechanical dissociation.
20. Kao AC, Treigt PV, Shaeffer-McCall, Shaw JP, Kuzil BB, Page RD, Higginbotham MB: Allograft diastolic dysfunction and chronotropic incompetence limited cardiac output response to exercise two to six years after heart transplantation. J Heart Lung Trans 1995, 14:11-22.
21. Mandak JS, Aaronson KD, Mancini DM: Serial assessment of exercise capacity after heart transplantation. J Heart Lung Transplant 1995, 14:468-478.
22. Stevenson LW, Sietsema Tillisch JH, Lem V, Walden J, Kobashigawa JA, Moriguchi J: Exercise capacity for survivors of cardiac transplantation or sustained medical therapy for stable heart failure. Circulation 1990, 81:78-85.
23. Grady KL, Jalowiec J, White-Williams C, Pifarre R, Kirklin JK, Bourge RC, Costanzo MR: Predictors of quality of life in patients with advanced heart failure awaiting transplantation. J Heart Lung Trans 1995, 14:2-10. Extensive multicenter study elucidating the factors determining coping abilities and quality of life in transplant candidates.
24. Walden JA, Stevenson LW, Dracup K, Hook JF, Moser DK, Hamilton M, Fonarow GC: Extended comparison of quality of life between heart failure patients and heart transplant recipients. J Heart Lung Trans 1994, 13:1109-1118. Extended follow-up of earlier study comparing patients with stable heart failure and transplant recipients. Both groups demonstrated some improvement, which was slightly more marked in the transplant recipients.
25. Stevenson WG, Stevenson LW, Middlekauff HR, Fonarow GC, Hamilton MA, Woo MA, Saxon LA, Natterson PD, Steimle A, Walden JA, Tillisch JH: Improving surviving for patients with advanced heart failure: a study of 737 consecutive patients. J Am Coll Cardiol 1995, 26:1417-1423. Report of 737 patients referred over a 7-year period relating improvements in one-year survival to changes in drug therapy.
26. Stevenson LW, Couper G, Natterson B, Fonarow GC, Hamilton MA, Woo M, Creaser JW: Target heart failure populations for newer therapies. Circulation 1995, 92(suppl 2):II-174-II-181. Detailed analysis of 265 patients referred with class IV symptoms and left ventricular ejection fraction of 25% or less, examining the limitations of various risk factors for identifying a group of ambulatory patients with high 1-year mortality.
27. DiSalvo TG, Mathier M, Semigran MJ, Dec GW: Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. J Am Coll Cardiol 1995, 25:1143-1153. Study of 67 potential transplant candidates demonstrating the prognostic utility of measuring right ventricular ejection fraction at rest and exercise.
28. Wilson JR, Schwartz JS, St. John Sutton M, Ferraro N, Horowitz LN, Reichek N, Josephson ME: Prognosis in severe heart failure; relation to hemodynamic measurements and ventricular ectopic activity. J Am Coll Cardiol 1983, 2:403-410.
29. Stevenson LW, Steimle AE, Fonarow G, Kermani M, Kermani D, Hamilton MA, Moriguchi JD, Walden J, Tillisch JH, Drinkwater DC, Laks H: Improvement in exercise capacity of candidates awaiting heart transplantation. J Am Coll Cardiol 1995, 25:163-170. Validation of a strategy using serial exercise testing and clinical assessment to identify ambulatory patients who can leave the transplant waiting list with good survival, despite initially meeting strict indications for transplantation.
30. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH Jr, Wilson JR: Value of peak oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991, 83:778-783.
31. Likoff M, Chandler S, Kay H: Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am J Cardiol 1987, 59:634-638.
32. Lee TH, Hamilton MA, Stevenson LW, Moriguchi JD, Fonarow GC, Child JS, Laks H, Walden JA: Impact of left ventricular cavity size on survival in advanced heart failure. Am J Cardiol 1993, 72:672-676.
33. Anguita M, Arizon JM, Bueno G, Latre JM, Sancho M, Torres F, Gimenez D, Concha M, Valles F: Clinical and hemodynamic predictors of survival in patients aged < 65 years with severe congestive heart failure secondary to ischemic or non-ischemic dilated cardiomyopathy. Am J Cardiol 1993, 72:413-417.
34. Kubo SH, Ormaza SM, Francis GS, et al.: Trends in patient selection for heart transplantation. J Am Coll Cardiol 1993, 21:975-981.
35. Keogh AM, Freund J, Baron DW: Timing of transplantation in idiopathic dilated cardiomyopathy. Am J Cardiol 1988, 61:418-422.
36. Gottlieb SS, Kukin ML, Ahern D, Packer M: Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. J Am Coll Cardiol 1989, 13:1534-1539.
37. Conti JB, Mills RM Jr: Mitral regurgitation and death while awaiting cardiac transplantation. Am J Cardiol 1993, 71:617-618.
38. Levine B, Kalman J, Mayer L, Fillit HM, Packer M: Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990, 323:236-241.
39. Hamilton MA, Stevenson LW, Luu M, Walden JA: Altered thyroid metabolism in advanced heart failure. J Am Coll Cardiol 1990, 16:91-95.
40. Middlekauff HR, Stevenson WG, Stevenson LW, Saxon LA: Syncope in advanced heart failure: high sudden death regardless of etiology. J Am Coll Cardiol 1993, 21:110-116.
41. Mancini DM, Wong KL, Simson MB: Prognostic value of an abnormal signal-averaged electrocardiogram in patients with non-ischemic congestive cardiomyopathy. Circulation 1993, 87:1083-1092.
42. Loisance D, Benvenuti C, Merlet P, Deleuze PH, Mazzucotelli JP, Hillion ML, Dubois-Rande JL, Castaigne A, Syrota A: Quels criteres de priorite pour l'inscription sur la liste d'attente d'un candidat a la transplantation cardiaque? Arch Mal Coeur 1995, 88:431-436.
43. Lee WH, Packer M: Prognostic importance of serum sodium concentration and its modification by converting enzyme inhibition in patients with severe chronic heart failure. Circulation 1986, 73:257-267.
44. Miller LW, Kubo SH, Young JB, Stevenson LW, Loh E, Costanzo MR: Report of the consensus conference on candidate selection for heart transplantatlon - 1993. J Heart Lung Trans 1995, 14:562-571. Detailed report of the Consensus Conference held in Boca Raton in 1993 representing 52 transplant centers in formulation of guidelines for medical therapy, selection, and reevaluation of transplant candidates.
45. Mudge GH, Goldstein S, Addonizio LJ, Caplan A, Mancini D, Levine TB, Ritsch ME, Stevenson LW: Cardiac transplantation: recipient guidelines/prioritization. J Am Coll Cardiol 1993, 22:21-31.
46. Hosenpud JO, Novick RJ, Breen TJ, Daily OP: The registry of the International Society for Heart and Lung Transplantation: Eleventh official report - 1994. J Heart Lung Transplant 1994, 13:561-570.
47. Bourge RC, Naftel DC, Costanzo MR, Kirklin JK, Young JB, Kubo SH, Olivari M-T, Kasper EK: Pretransplantation risk factors for death after heart transplantation: a multi-institutional study. J Heart Lung Trans 1993, 12:549-562.
48. Kesler KA, Hanosh JJ, O'Donnell J, Faust S, Turrentine MW, Mahomen Y, Brown JW: Heart transplantation in patients with Marian's syndrome. J Heart Lung Trans 1994, 13:889-904.
49. Blanche C, Valenza M, Czer LS, Barath P, Admon D I Harasty D, Utley C, Trento A: Combined heart and kidney transplantation with allografts from the same donor. Ann Thorac Surg 1994, 58:1135-1138.
50. Sharples LD, Roberts M, Parameshwar J, Schofield PM, Wallwork J, Large SR: Heart transplantation in the United Kingdom: who waits longest and why. J Heart Lung Trans 1995, 14:236-243.
51. Mehta SM, Aufiero TX, Pae WE, Miller CA, Pierce WS: Combined registry for the clinical use of the mechanical ventricular assist pumps and the total artificial heart in conjunction with heart transplantation: six office report. 1994. J Heart Lung Transplant 1995, 14:585-593. Registry report summarizing current experience using mechanical support devices as bridges to transplantation.
52. Oz MC, Goldstein DJ, Pepino P: Screening scale predicts patients successfully receiving long-term implantable left ventricular assist devices. Circulation 1995, 92(suppl 2):II-169-II-173. Distillation of considerable experience into a proposal for a screening scale to select patients for insertion of mechanical support devices.
53. Stevenson LW, Hamilton MA, Tillisch JH, Moriguchi JD, Kobashigawa JA, Drinkwater D, Laks H, Creaser JA: Decreasing survival benefit from cardiac transplantation for outpatients as the waiting list lengthens. J Am Coll Cardiol 1991, 18:919-925.
54. Kao W, McGee D, Liao Y, Heroux AL, Mullen GM, Johson MR, Costanzo MR: Does heart transplantation confer additional benefit over medical therapy to patients who have waited > 6 months for heart transplantation? J Am Coll Cardiol 1994, 24:1547-1551. Important analysis of current outcomes on the transplant waiting list, demonstrating success of the current priority system when patients are followed closely for evidence of deterioration.